📇 Rhumatologue · LA ROCHE SUR YON · (85) · Libéral

MME Amandine PELLETIER

Pourquoi vous devez consulter ce praticien

4 raisons identifiées

Encadrant universitaire
Forme la prochaine génération de rhumatologues (4 thèses dirigées)
Praticien-chercheur
15 articles scientifiques publiés — formation continue solide
Expérience confirmée
15 ans d'exercice en rhumatologie — recul clinique solide
Délais de RDV courts dans la région
97.1 rhumatos / 100 000 hab. — département bien doté

Rhumatologue

📍 LA ROCHE SUR YON (85)LibéralRPPS 10100915783

EnseignementExpérience confirmée

15ans d'exercice (thèse 2011)

📊 Reconnaissance scientifique : 14/100📝 53 articles publiés🇫🇷 Publications académiques françaises (8)🎓 4 thèses dirigées

Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.

Top publications · les plus citées

Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort

Alimentary pharmacology & therapeutics · 2018

📚 94 citations🎯 RCR 4.32Top 10% NIH🩺 Clinique🔓 Open Access📄 PDF gratuit ↗

Lire l'abstract Crossref ↓

SummaryBackgroundThe effectiveness of vedolizumab as a treatment for extraintestinal manifestations (EIM) is questionable due to its gut‐specificity.AimTo assess effectiveness of vedolizumab for EIM in patients with inflammatory bowel disease (IBD) in a large real‐life experience cohort.MethodsBetween June and December 2014, 173 patients with Crohn's disease and 121 with ulcerative colitis were treated with vedolizumab. Patients were followed until week 54. EIM activity was assessed at weeks 0, 6, 14, 22, 30 and 54 by using a 3‐step scale: complete remission, partial response and no response.ResultsAt baseline, 49 (16.7%) patients had EIMs of which 47 had inflammatory arthralgia/arthritis, four had cutaneous lesions and two had both rheumatologic and skin EIM. At week 54, 21 (44.7%) patients had complete remission for inflammatory arthralgia/arthritis and three (75%) for cutaneous EIM. In multivariate analysis, complete remission of inflammatory arthralgia/arthritis was associated with clinical remission of IBD (OR = 1.89, IC95% [1.05‐3.41], P = .03) and recent onset of inflammatory arthralgia/arthritis (OR = 1.99, IC95% [1.12‐3.52], P = .02). During the follow‐up period, 34 (13.8%) patients without any EIM at baseline, developed incident cases of inflammatory arthralgia/arthritis consisting mostly of peripheral arthralgia without evidence of arthritis and 14 (4.8%) incident cases of paradoxical skin manifestation.ConclusionVedolizumab therapy is commonly associated with improvement in EIM. This was associated with quiescent IBD and recent EIM. However, paradoxical skin manifestation and inflammatory arthralgia/arthritis may occur upon vedolizumab therapy.

Vascular Cerebral Damage in Frail Older Adults: The AMImage Study

The journals of gerontology. Series A, Biological sciences and medical sciences · 2017

📚 55 citations🎯 RCR 2.82Top 18% NIH🔓 Open Access📄 PDF gratuit ↗

Clinical outcome after a totally implantable venous access port-related infection in cancer patients: a prospective study and review of the literature

Medicine · 2012

📚 53 citations🎯 RCR 2.34Top 22% NIH

Cookies & analyse de trafic

MME Amandine PELLETIER

Pourquoi vous devez consulter ce praticien

Thèses universitaires

Direction de thèses

Activité de recherche & publications

Publications académiques en France

Lieu de consultation

Tarifs & secteur de conventionnement

Prendre rendez-vous & contact

Top publications · les plus citées

Publications scientifiques (15) — classées par pathologie

Transversal7

Santé mentale / fatigue3

Revue générale2

Épidémiologie & registres1

Gériatrie1

Pédiatrie1

Revue / méta-analyse1

Partager cette fiche